Single treatment of PCCs with ATRA showed no effects on cancer cell aggressiveness, while drug combination of ATRA and chemotherapy drugs like GEM could markedly decrease tumor growth, epithelial-mesenchymal transition (EMT) as well as modulating several signaling pathways (e.g. Wnt, SHH) in KPC mice (177). The gene discussed is SHH; the disease is neoplasm.